Aptevo Therapeutics
(NASDAQ) APVO
Aptevo Therapeutics Financials at a Glance
Market Cap
$4.26M
Revenue (TTM)
$220.00K
Net Income (TTM)
$27.54M
EPS (TTM)
$-1779.06
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.30
Volume
1,420
Open
$4.44
Price
$4.30
Volume
1,420
Open
$4.44
Previous Close
$4.30
Daily Range
$4.30 - $4.50
52-Week Range
$3.95 - $1299.60
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.30
Volume
1,420
Open
$4.44
Previous Close
$4.30
Daily Range
$4.30 - $4.50
52-Week Range
$3.95 - $1299.60
APVO News
APVO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aptevo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
36
CEO
Marvin L. White, MBA
Website
www.aptevotherapeutics.comHeadquarters
Seattle, WA 98121, US
APVO Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
120%
Net Income Margin
125%
Return on Equity
-248%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-0.33%
Stock Overview
Market Cap
$4.26M
Shares Outstanding
997.80K
Volume
1.42K
Short Interest
0.00%
Avg. Volume
174.38K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$26.31M
EBITDA
$26.31M
Operating Cash Flow
$25.59M
Capital Expenditure
$0.00
Free Cash Flow
$25.59M
Cash & ST Invst.
$21.62M
Total Debt
$4.63M
Aptevo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$220.00K
N/A
Gross Profit
$110.00K
-54.9%
Gross Margin
50.00%
N/A
Market Cap
$4.26M
N/A
Market Cap/Employee
$115.15K
N/A
Employees
37
N/A
Net Income
$7.38M
-16.9%
EBITDA
$5.89M
+6.7%
Quarterly Fundamentals
Net Cash
$16.99M
+315.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.76M
-18.7%
Short Term Debt
$866.00K
N/A
Return on Assets
-1.01%
N/A
Return on Invested Capital
-1.24%
N/A
Free Cash Flow
$5.24M
+9.1%
Operating Cash Flow
$5.24M
+9.1%